Immunotherapy with Pembrolizumab has proved highly
effective for a small proportion of men with advanced prostate
cancer that was not responding to other treatment.
Contact: info@neat-news.com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
The page is maintained in Germany and for any legal matters the laws of Germany apply.
Any warranty or liability is excluded in the widest legally possible sense.